4LL Stock Chart & Stats
€4.89
-€0.10(-1.03%)
At close: 4:00 PM EST
€4.89
-€0.10(-1.03%)
Day’s Range― - ―
52-Week Range€3.71 - €8.57
Previous CloseN/A
Volume480.00
Average Volume (3M)478.00
Market Cap
€1.39B
Enterprise Value€1.26K
Total Cash (Recent Filing)€750.74M
Total Debt (Recent Filing)€1.04B
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Jul 29, 2026EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding180,513,090
10 Day Avg. Volume436
30 Day Avg. Volume478
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.89
Price to Sales (P/S)0.49
P/FCF Ratio4.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€6.73Price Target Upside37.70% Upside
Rating ConsensusHold
Number of Analyst Covering16
EPS Forecast (FY)-0.8
Revenue Forecast (FY)€2.20B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent positive operating and free cash flow (~$288M and ~$251M TTM) supports ongoing investments, working-capital needs and debt repayment. This durable cash conversion gives management flexibility to fund growth initiatives and deleveraging without relying on equity raises.
Integrated Care Scale And Margin ExpansionLarge membership base (101.2M) and growing chronic-care enrollments provide a durable B2B revenue foundation and cross-sell runway. Improving Integrated Care margins reflect operational leverage in core contracts, supporting sustainable profitability as utilization and program penetration expand.
BetterHelp Insurance Rollout MomentumShifting BetterHelp toward insurance coverage is a structural business-model change that increases recurring, insurer-backed revenue and session frequency. Insurance adoption (credentialed providers and large contracted lives) should stabilize demand and improve long-term monetization vs cash-pay volatility.
Bears Say
Persistent Operating LossesOngoing negative operating profit and net losses constrain internal capital for strategic investment and shareholder returns. Even with positive cash flow, persistent losses indicate the company must sustain margin recovery to convert scale into durable GAAP profitability and stronger ROE.
Uneven Revenue Trends And Recent DeclinesInconsistent top-line growth and a recent revenue drop undermine margin recovery prospects and complicate multi-quarter planning. Reliance on contract timing, mix shifts (subscription to visit) and BetterHelp softness makes sustainable revenue momentum uncertain until adoption and mix stabilize.
High Gross Debt And Convertible-note UncertaintyElevated gross leverage and a near-term convertible-note maturity create refinancing and capital-structure risk. Debt overhang can restrict strategic flexibility, require cash earmarking for liabilities, and leave outcomes sensitive to execution of the outlined deleveraging plan.
Teladoc News
4LL FAQ
What was Teladoc Inc.’s price range in the past 12 months?
Teladoc Inc. lowest stock price was €3.71 and its highest was €8.57 in the past 12 months.
What is Teladoc Inc.’s market cap?
Teladoc Inc.’s market cap is €1.39B.
When is Teladoc Inc.’s upcoming earnings report date?
Teladoc Inc.’s upcoming earnings report date is Jul 29, 2026 which is in 4 days.
How were Teladoc Inc.’s earnings last quarter?
Teladoc Inc. released its earnings results on Apr 29, 2026. The company reported -€0.316 earnings per share for the quarter, missing the consensus estimate of -€0.3 by -€0.017.
Is Teladoc Inc. overvalued?
According to Wall Street analysts Teladoc Inc.’s price is currently Undervalued.
Does Teladoc Inc. pay dividends?
Teladoc Inc. does not currently pay dividends.
What is Teladoc Inc.’s EPS estimate?
Teladoc Inc.’s EPS estimate is -0.22.
How many shares outstanding does Teladoc Inc. have?
Teladoc Inc. has 180,513,090 shares outstanding.
What happened to Teladoc Inc.’s price movement after its last earnings report?
Teladoc Inc. reported an EPS of -€0.316 in its last earnings report, missing expectations of -€0.3. Following the earnings report the stock price went down -9.327%.
Which hedge fund is a major shareholder of Teladoc Inc.?
Currently, no hedge funds are holding shares in DE:4LL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teladoc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€6.73 (37.70% Upside)
€6.73 (37.70% Upside)
Blogger Sentiment
Bullish
DE:4LL Sentiment 70%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-18.50%
Trailing 12-Months
Company Description
Teladoc Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
4LL Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
4LL Stock 12 Month Forecast
Average Price Target
€6.73
▲(37.70% Upside)